Registro:

Referencias:

• Cardoso, M.S., Reis-Cunha, J.L., Bartholomeu, D.C., Evasion of the immune response by Trypanosoma cruzi during acute infection (2015) Front Immunol, 6, p. 659
• Machado, F.S., Dutra, W.O., Esper, L., Gollob, K.J., Teixeira, M.M., Factor, S.M., Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease (2012) Semin Immunopathol, 34, pp. 753-770
• Trujillo, M., Budde, H., Piñeyro, M.D., Stehr, M., Robello, C., Flohé, L., Trypanosoma brucei and Trypanosoma cruzi tryparedoxin peroxidases catalytically detoxify peroxynitrite via oxidation of fast reacting thiols (2004) J Biol Chem, 279, pp. 34175-34182
• Piacenza, L., Peluffo, G., Alvarez, M.N., Kelly, J.M., Wilkinson, S.R., Radi, R., Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage-and endogenously-derived peroxynitrite (2008) Biochem J, 410, pp. 359-368
• Wilkinson, S.R., Temperton, N.J., Mondragon, A., Kelly, J.M., Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi (2000) J Biol Chem, 275, pp. 8220-8225
• Piñeyro, M.D., Parodi-Talice, A., Arcari, T., Robello, C., Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease? (2008) Gene, 408, pp. 45-50
• Piñeyro, M.D., Arcari, T., Robello, C., Radi, R., Trujillo, M., Tryparedoxin peroxidases from Trypanosoma cruzi: high efficiency in the catalytic elimination of hydrogen peroxide and peroxynitrite (2011) Arch Biochem Biophys, 507, pp. 287-295
• MaD, P., Pizarro, J.C., Lema, F., Pritsch, O., Cayota, A., Bentley, G.A., Crystal structure of the tryparedoxin peroxidase from the human parasite Trypanosoma cruzi (2005) J Struct Biol, 150, pp. 11-22
• Gadelha, F., Gonçalves, C., Mattos, E., Alves, M., Pineyro, M., Robello, C., Release of the cytosolic tryparedoxin peroxidase into the incubation medium and a different profile of cytosolic and mitochondrial peroxiredoxin expression in H 2 O 2 -treated Trypanosoma cruzi tissue culture-derived trypomastigotes (2013) Exp Parasitol, 133, pp. 287-293
• Piacenza, L., Peluffo, G., Alvarez, M.N., Martínez, A., Radi, R., Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease (2013) Antioxid Redox Signal, 19, pp. 723-734
• Alvarez, M.N., Peluffo, G., Piacenza, L., Radi, R., Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi consequences for oxidative killing and role of microbial peroxiredoxins in infectivity (2011) J Biol Chem, 286, pp. 6627-6640
• Atwood, J., Weatherly, D., Minning, T., Bundy, B., Cavola, C., Opperdoes, F., The Trypanosoma cruzi proteome (2005) Science, 309, pp. 473-476
• Parodi-Talice, A., Monteiro-Goes, V., Arrambide, N., Avila, A., Duran, R., Correa, A., Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis (2007) J Mass Spectrom, 42, pp. 1422-1432
• Piacenza, L., Alvarez, M.N., Peluffo, G., Radi, R., Fighting the oxidative assault: the Trypanosoma cruzi journey to infection (2009) Curr Opin Microbiol, 12, pp. 415-421
• Zago, M.P., Hosakote, Y.M., S-j, K., Dhiman, M., Piñeyro, M.D., Parodi-Talice, A., TcI isolates of Trypanosoma cruzi exploit the antioxidant network for enhanced intracellular survival in macrophages and virulence in mice (2016) Infect Immun, 84, pp. 1842-1856
• Ishii, T., Warabi, E., Yanagawa, T., Novel roles of peroxiredoxins in inflammation, cancer and innate immunity (2012) J Clin Biochem Nutr, 50, pp. 91-105
• Riddell, J.R., Wang, X.-Y., Minderman, H., Gollnick, S.O., Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4 (2010) J Immunol, 184, pp. 1022-1030
• Donnelly, S., O'Neill, S.M., Sekiya, M., Mulcahy, G., Dalton, J.P., Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages (2005) Infect Immun, 73, pp. 166-173
• Donnelly, S., Dalton, J.P., Loukas, A., (2006) Proteases in Helminth-and Allergen-Induced Inflammatory Responses, pp. 45-64. , Parasites and Allergy. 90., Basel, Switzerland, Karger Publishers
• Furuta, T., Imajo-Ohmi, S., Fukuda, H., Kano, S., Miyake, K., Watanabe, N., Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin (2008) Eur J Immunol, 38, pp. 1341-1350
• Knoops, B., Argyropoulou, V., Becker, S., Ferté, L., Kuznetsova, O., Multiple roles of peroxiredoxins in inflammation (2016) Mol Cells, 39, p. 60
• Marshall, E.S., Elshekiha, H.M., Hakimi, M.-A., Flynn, R.J., Toxoplasma gondii peroxiredoxin promotes altered macrophage function, caspase-1-dependent IL-1β secretion enhances parasite replication (2011) Vet Res, 42, p. 80
• Menezes Cabral, S., Leal Silvestre, R., Moreira Santarém, N., Costa Tavares, J., Franco Silva, A., Cordeiro-da-Silva, A., A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin (2008) Immunology, 123, pp. 555-565
• Bern, C., Montgomery, S.P., Herwaldt, B.L., Rassi, A., Marin-Neto, J.A., Dantas, R.O., Evaluation and treatment of Chagas disease in the United States: a systematic review (2007) JAMA, 298, pp. 2171-2181
• Mamat, U., Wilke, K., Bramhill, D., Schromm, A.B., Lindner, B., Kohl, T.A., Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins (2015) Microb Cell Fact, 14, p. 57
• Longhi, S.A., Atienza, A., Prados, G.P., Buying, A., Balouz, V., Buscaglia, C.A., Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas’ disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins (2014) PLoS Negl Trop Dis, 8
• Levy, G.V., Tasso, L.M., Longhi, S.A., Rivello, H.G., Kytö, V., Saukko, P., Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells (2011) Int J Parasitol, 41, pp. 635-644
• Larsen, J.E.P., Lund, O., Nielsen, M., Improved method for predicting linear B-cell epitopes (2006) Immunome Res, 2, p. 2
• Haste Andersen, P., Nielsen, M., Lund, O., Prediction of residues in discontinuous B-cell epitopes using protein 3D structures (2006) Protein Sci, 15, pp. 2558-2567
• (2013) R: A language and environment for statistical computing
• Bates, D.M., (2010) lme4: Mixed-effects modeling with R
• de Oliveira Mendes, T.A., Cunha, J.L.R., de Almeida Lourdes, R., Luiz, G.F.R., Lemos, L.D., dos Santos, A.R.R., Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays (2013) PLoS Negl Trop Dis, 7
• Acevedo, G.R., Longhi, S.A., Bunying, A., Sabri, N., Atienza, A., Zago, M.P., Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients (2017) PLoS ONE, 12
• Nogueira, F.B., Ruiz, J.C., Robello, C., Romanha, A.J., Murta, S.M., Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole (2009) Parasitol Res, 104, pp. 835-844
• Wilkinson, S.R., Kelly, J.M., The role of glutathione peroxidases in trypanosomatids (2003) Biol Chem, 384, pp. 517-525
• Abel, L.C., Rizzo, L.V., Ianni, B., Albuquerque, F., Bacal, F., Carrara, D., Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection (2001) J Autoimmun, 17, pp. 99-107
• Ribeirao, M., Lücia, V., Ferguson, P.C., Rénia, L., Fragata Filho, A.A., Schenkman, S., Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase (2000) Parasite Immunol, 22, pp. 49-53
• Michailowsky, V., Luhrs, K., Rocha, M.O.C., Fouts, D., Gazzinelli, R.T., Manning, J.E., Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas’ disease (2003) Infect Immun, 71, pp. 3165-3171
• Lorena, V., Lorena, I., Braz, S., Melo, A., Melo, M., Melo, M., Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi (2010) Scand J Immunol, 72, pp. 529-539
• de Melo, A.S., de Lorena, V.M.B., de Moura Braz, S.C., Docena, C., de Miranda Gomes, Y., IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi (2012) Cytokine, 58, pp. 207-212
• Morán-Utrera, Y., López-Monteon, A., Rosales-Encina, J.L., Méndez-Bolaina, E., Ramos-Ligonio, A., Trypanosoma cruzi SSP4 amastigote protein induces expression of immunoregulatory and immunosuppressive molecules in peripheral blood mononuclear cells (2012) J Trop Med, 2012, p. 829139
• Leng, S.X., McElhaney, J.E., Walston, J.D., Xie, D., Fedarko, N.S., Kuchel, G.A., ELISA and multiplex technologies for cytokine measurement in inflammation and aging research (2008) J Gerontol A Biol Sci Med Sci, 63, pp. 879-884
• Anthony, D.D., Milkovich, K.A., Zhang, W., Rodriguez, B., Yonkers, N.L., Tary-Lehmann, M., Dissecting the T cell response: proliferation assays vs. cytokine signatures by ELISPOT (2012) Cells, 1, pp. 127-140
• Sallusto, F., Geginat, J., Lanzavecchia, A., Central memory and effector memory T cell subsets: function, generation, and maintenance (2004) Annu Rev Immunol, 22, pp. 745-763
• Fiuza, J.A., Fujiwara, R.T., Gomes, J.A.S., das Costa Rocha, M.O., Chaves, A.T., de Araújo, F.F., Profile of central and effector memory T cells in the progression of chronic human Chagas disease (2009) PLoS Negl Trop Dis, 3
• Villanueva-Lizama, L.E., Cruz-Chan, J.V., Aguilar-Cetina, A., Herrera-Sanchez, L.F., Rodriguez-Perez, J.M., Rosado-Vallado, M.E., Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and-B supertypes in Chagasic chronic patients from Mexico (2018) PLoS Negl Trop Dis, 12
• Bankovich, A.J., Shiow, L.R., Cyster, J.G., CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4 (2010) J Biol Chem, 285, pp. 22328-22337
• González-Amaro, R., Cortés, J.R., Sánchez-Madrid, F., Martín, P., Is CD69 an effective brake to control inflammatory diseases? (2013) Trends Mol Med, 19, pp. 625-632
• Campos-Neto, A., Porrozzi, R., Greeson, K., Coler, R.N., Webb, J.R., Seiky, Y.A., Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease (2001) Infect Immun, 69, pp. 4103-4108
• Fereig, R.M., Kuroda, Y., Terkawi, M.A., Mahmoud, M.E., Nishikawa, Y., Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice (2017) PLoS ONE, 12
• Daifalla, N.S., Bayih, A.G., Gedamu, L., Differential immune response against recombinant Leishmania donovani peroxidoxin 1 and peroxidoxin 2 proteins in BALB/c mice (2015) J Immunol Res, 2015, p. 348401
• Bontempi, I., Fleitas, P., Poato, A., Vicco, M., Rodeles, L., Prochetto, E., Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi (2017) Immunotherapy, 9, pp. 555-565

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------